Welcome to the Division of Cancer Biology (DCB) of the National Cancer
Institute (NCI). DCB was created by the reorganization of NCI in 1995,
and has the principal Federal responsibility for managing a grant- and
contract-supported program of basic and applied research on cancer cell
biology, including research on carcinogenesis and cancer immunology. In
addition to investigating basic cellular mechanisms, this research includes
examination of the role of biological, chemical, and physical agents in
the initiation, promotion or inhibition of cancer and the biological and
health effects of exposures to ionizing and non-ionizing radiation.
The staff of DCB is dedicated to working with the scientific community
in the pursuit of knowledge and discovery about the biology of cancer and
encourages researchers to consult the staff to learn more about available
opportunities for research support and to discuss strategies for successful
grant competition. We can assist qualified individuals in locating needed
resources or collaborators, and are interested in assisting investigators
in obtaining NIH research support which will in turn strengthen our national
effort to fight cancer.
PROGRESS REPORT REMINDER: NIH no longer mails pre-printed face pages for progress reports. Beginning with non-competing renewal start dates of December 2002 and beyond, grantees will need to access an NIH Office of Extramural Research website to determine which progress reports are due. Progress reports for grants funded by NCI should be sent to:
National Cancer Institute (NCI)
Records Management Center
Executive Plaza South
6120 Executive Boulevard, Room T42, MSC 7107
Bethesda, MD 20892-7107
Express Mail/Courier Service: Rockville MD 20852
Phone: (301) 496-7753
FAX: (301) 402-3409
The Activities to Promote Research Collaborations (APRC) initiative provides limited supplemental support to current DCB-funded investigators for meetings/workshops or grant-related research activities to establish focused scientific research collaboration in novel and promising areas related to the parent grant. Information about this initiative can be found at http://www3.cancer.gov/dcb/APRC2003.htm or contact your DCB Program Director. The deadlines for submitting supplement applications are December 16th and April 15th.
The Division of Cancer Biology, NCI is participating in 5 new Initiatives: PA03-008 Bone Anabolic Hormones, Their Receptors and Signal Transduction Pathways, PA-02-116 Age-Related Prostate Growth: Biologic Mechanisms, CA-03-013 Molecular Interaction Between Tumor Cells and Bone (receipt date: November 21, 2002), PA-02-100 Complex Formation in Hormonal Regulation of Gene Expression and PA-02-013,
Pilot and Feasibility Program in Urology (active through October 1, 2004).
The National Cancer Institute (NCI) is excited to introduce the NCI Research Resources website. This one-of-a-kind directory includes over 100 products and services developed by the NCI that are available to basic, clinical and epidemiological researchers without extensive negotiations or intellectual property issues. The resources include specimens, datasets, computer software, chemicals, and more. The NCI Research Resources website was developed to facilitate the search for NCI resources as well as advertise their availability to the scientific community. The NCI Research Resources website is integral to NCI’s commitment to provide the research community with tools and infrastructure to speed cancer research.
Updated information on grant policies
and grant related activities is available here.
DCB Representation at Professional Meetings:
If you would like to talk with any of our staff at these meetings, please
leave a note for the staff member on the message board/service.
Future meetings: DCB program staff will be
attending a number of meetings in 2002 and will make time available between attendance at scientific sessions to meet with grantees and potential applicants.
Specific meetings will be listed here as plans are made.
PROGRESS REPORT REMINDER: NIH no longer mails pre-printed face pages for progress reports. Beginning with non-competing renewal start dates of December 2002 and beyond, grantees will need to access an NIH Office of Extramural Research website to determine which progress reports are due. Progress reports for grants funded by NCI should be sent to: